Market Place
Sourcing Support
Orsini Now Provider for SAJAZIR Injection in Acute HAE Attacks
05 Nov 2024 //
PR NEWSWIRE
Vanda Pharmaceuticals rejects Cycle Pharma`s second takeover offer
15 Oct 2024 //
REUTERS
Vanda rejects Future Pak and Cycle Pharma`s takeover offers
20 Jun 2024 //
REUTERS
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
07 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Cycle Unveils $8/Share All-Cash Proposal To Acquire Vanda
06 Jun 2024 //
BUSINESSWIRE
New Tiopronin Delayed-Release Tablets Launch With US Patient Support
13 May 2024 //
BUSINESSWIRE
ORMALVI™: US Product Launch for Primary Periodic Paralysis
08 May 2024 //
BUSINESSWIRE
Drug, TASCENSO ODT , Launched to Meet the Needs of Multiple Sclerosis Patients
13 Feb 2023 //
BUSINESSWIRE
Cycle Pharmaceuticals launches SAJAZIRTM Injection, in Hereditary Angioedema
28 Sep 2021 //
BUSINESSWIRE
Cycle Pharmaceuticals Launches Cycle Vita for Rare Disease Patients
13 Sep 2021 //
BUSINESSWIRE
FDA Approvals Roundup: Detectnet, Nityr, Trelegy Ellipta
16 Sep 2020 //
RAPS
US FDA Grants Once Daily Dosing Option for NITYR Tablets for HT-1 Patients
14 Sep 2020 //
BUSINESSWIRE
Cycle Pharmaceuticals Secures $25 Million Debt Financing
06 Sep 2020 //
BUSINESSWIRE
Cycle Pharmaceuticals and Medherant partner on transdermal delivery tech
01 Jun 2020 //
MANUFACTURINGCHEMIST
Cycle & Medherant Partner to Develop Medicines using the TEPI Patch®
05 May 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.